Skip to content
#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Image: PA Images

AstraZeneca may have used outdated information in trial – US health officials

AstraZeneca reported on Monday that its Covid-19 vaccine provided strong protection among adults of all ages in a long-anticipated US study,
Mar 23rd 2021, 8:20 AM 25,339 24

RESULTS FROM A US trial of AstraZeneca’s Covid-19 vaccine may have used “outdated information”, according to federal health officials in the country.

The Data and Safety Monitoring Board said it was concerned that AstraZeneca may have provided an incomplete view of the efficacy data.

AstraZeneca reported on Monday that its Covid-19 vaccine provided strong protection among adults of all ages in a long-anticipated US study, a finding that could help rebuild public confidence in the jab around the world and move it a step closer to clearance in the US.

In the study of 30,000 people, the vaccine was 79% effective at preventing symptomatic cases of Covid-19 – including in older adults.

There were no severe illnesses or hospital admissions among vaccinated volunteers, compared with five such cases in participants who received dummy shots – a small number, but consistent with findings from Britain and other countries that the vaccine protects against the worst of the disease.

AstraZeneca also said the study’s independent safety monitors found no serious side-effects, including no increased risk of rare blood clots like those identified in Europe, a scare that led numerous countries to briefly suspend vaccinations last week.

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Support us now

The company aims to file an application with the Food and Drug Administration in the coming weeks, and the government’s outside advisers will publicly debate the evidence before the agency makes a decision.

Authorisation and guidelines for use of the vaccine in the United States will be determined by the Food and Drug Administration and Centres for Disease Control and Prevention after a thorough review of the data by independent advisory committees.

Send a tip to the author

Press Association

COMMENTS (24)

This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

    Leave a comment

     
    cancel reply
    Back to top